Impact of Pilates Exercise in Children With Juvenile Idiopathic Arthritis (Arthritis)
Impact of Clinical Pilates Exercise on Pain, Cardiorespiratory Fitness, Functional Ability, And Quality of Life in Children With Polyarticular Juvenile Idiopathic Arthritis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Riyadh
-
Al-Kharj, Riyadh, Saudi Arabia, 11432
- Outpatient Clinic of College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Polyarticular JIA per the International League of Associations for Rheumatology classification.
- Age ranges from 10 to14 years.
- Stable medical treatment.
Exclusion Criteria:
- If they had contractures.
- Congenital anomalies.
- History of surgery.
- History of systemic disease
- Cardiorespiratory co-morbidity.
- Participation in regular exercises or sports activity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: experimental group
Patients in the study group received Pilates exercises plus conventional physical therapy program
|
Mat, Pilates band or elastic bands, and Pilate's ball
Other Names:
pain relief, increasing flexibility, and mobility, improving muscle strength
Other Names:
|
|
Experimental: control group
Patients in the control group received conventional physical therapy
|
pain relief, increasing flexibility, and mobility, improving muscle strength
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain assessment
Time Frame: at baseline
|
measured using visual analog scale.
A score of zero means no pain, while a score often means significant pain.
|
at baseline
|
|
Pain assessment
Time Frame: after 12 weeks
|
measured using visual analog scale.
A score of zero means no pain, while a score often means significant pain.
|
after 12 weeks
|
|
Cardiorespiratory fitness assessment
Time Frame: at baseline
|
assessed using electromagnetic cycle ergometer with electronic braking
|
at baseline
|
|
Cardiorespiratory fitness assessment
Time Frame: after 12 weeks
|
assessed using electromagnetic cycle ergometer with electronic braking
|
after 12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional ability assessment
Time Frame: at baseline
|
assessed using The Childhood Health Assessment Questionnaire
|
at baseline
|
|
Functional ability assessment
Time Frame: after 12 weeks
|
assessed using The Childhood Health Assessment Questionnaire
|
after 12 weeks
|
|
health-related quality of life
Time Frame: at baseline
|
assessed using The self-report Pediatric Quality of Life Inventory
|
at baseline
|
|
health-related quality of life
Time Frame: after 12 weeks
|
assessed using The self-report Pediatric Quality of Life Inventory
|
after 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Alshimaa Azab, PhD, Cairo University
- Study Director: Maged Basha, PhD, Qassim University
Publications and helpful links
General Publications
- Franco CB, Ribeiro AF, Morcillo AM, Zambon MP, Almeida MB, Rozov T. Air stacking: effects of Pilates mat exercises on muscle strength and on pulmonary function in patients with cystic fibrosis. J Bras Pneumol. 2014 Oct;40(5):521-7. doi: 10.1590/s1806-37132014000500008.
- Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chedeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, Rosenberg AM, Cameron B, Johnson N, Dorval J, Scuccimarri R, Campillo S, Petty RE, Duffy KN, Boire G, Haddad E, Houghton K, Laxer R, Turvey SE, Miettunen P, Gross K, Guzman J, Benseler S, Feldman BM, Espinosa V, Yeung RS, Tucker L. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res (Hoboken). 2010 Apr;62(4):527-36. doi: 10.1002/acr.20044.
- Haverman L, Grootenhuis MA, van den Berg JM, van Veenendaal M, Dolman KM, Swart JF, Kuijpers TW, van Rossum MA. Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a Web-based survey. Arthritis Care Res (Hoboken). 2012 May;64(5):694-703. doi: 10.1002/acr.21609.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RHPT/0020/0035
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.